Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 12 Show results per page	View Search Criteria \| Help With Results

Last Modified: 6/1/1994


1.		Phase III Randomized, Double-Blind Study of Macrophage Colony-Stimulating Factor vs Placebo, Each with Standard Amphotericin-B Therapy, in Cancer Patients with Definitive or Probable Invasive Candidiasis (Summary Last Modified 06/94)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Closed				3 and over								EORTC-19922

Last Modified: 12/1/1989


2.		Phase I/II Evaluation of Macrophage Colony Stimulating Factor in Patients with Advanced Cancer (Summary Last Modified 12/89)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				any age				NCI				NCI-89-C-167A NCI-T89-0082N, T89-0082

Last Modified: 11/1/1994


3.		Phase II Study of Intravenous M-CSF Administered for Four 7-Day Courses for non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia in First, Second, or Third Relapse (Summary Last Modified 11/94)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over								GENE-C9202-04 NCI-V94-0410

Last Modified: 12/1/1992


4.		Phase II Trial of Murine Monoclonal Antibody D6.12 plus M-CSF in Patients with Advanced Colorectal or Gastric Carcinoma (Summary Last Modified 12/92)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over								UAC-2129 NCI-B92-0003, B92-0003

Last Modified: 8/1/1991


5.		Phase IA/IB Study of rM-CSF in Patients with Cancer (Summary Last Modified 08/91)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				18 and over								CCF-RPC-3272A NCI-B90-0001, B90-0001

Last Modified: 6/1/1991


6.		Phase I Study of M-CSF in Patients with Myelodysplastic Syndrome (Summary Last Modified 06/91)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				18 and over								AECM-9006164 NCI-V90-0128

Last Modified: 11/1/1990


7.		Phase I Study of Recombinant Human M-CSF in Patients with Acute Myelogenous Leukemia (Summary Last Modified 11/90)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				18 and over								AECM-9006166 NCI-V90-0129

Last Modified: 4/1/1991


8.		Phase I Study of M-CSF in Pediatric Patients with Refractory Neuroblastoma, Osteosarcoma, and Other GD2- and GD3-Positive Tumors (Summary Last Modified 04/91)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				child								MSKCC-90114 NCI-V91-0010

Last Modified: 9/1/1992


9.		Phase I Study of M-CSF/IFN-G in Patients with Advanced Malignancies (Summary Last Modified 09/92)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				18 and over				NCI				FCCC-90073 NCI-T90-0157D, T90-0157

Last Modified: 6/1/1992


10.		Phase I Study of MOAB R24/M-CSF in Patients with Advanced Melanoma (Summary Last Modified 06/92)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				over 18								MSKCC-91017 NCI-B90-0015, B90-0015

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute